Literature DB >> 18068098

Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.

Taek Joon Yoon1, Tack Joong Kim, Hwa Lee, Kwang Soon Shin, Yeo Pyo Yun, Won Kook Moon, Dong Woo Kim, Kwang Ho Lee.   

Abstract

The beta-glucans isolated from Saccharomyces cerevisiae (S. cerevisiae) enhance the innate immune system, but there is little evidence for its antitumor activity. To examine the antitumor and immunostimulating activities of beta-glucan (IS-2) purified from mutated S. cerevisiae, we made an experiment on innate immune response against metastasis of cancer cells by comparing with the beta-glucan from wild-type S. cerevisiae. In experimental lung metastasis of colon 26-M3.1 carcinoma or B16-BL6 melanoma cells, prophylactic administration of beta-glucan purified from mutated S. cerevisiae significantly inhibited lung metastasis in a dose-dependent manner. Furthermore, therapeutic administration of IS-2 also significantly inhibited the colon 26-M3.1 cell growth in mice. In an assay of liver and spleen metastasis produced by i.v. inoculation of L5178Y-ML25 lymphoma cells, IS-2 also significantly inhibited metastasis in CDF1 mice. Furthermore, pretreatment with IS-2 two days before tumor inoculation significantly prolonged the survival time of tumor-bearing mice. In an in vitro cytotoxicity analysis, IS-2 (up to 100 microg/ml) did not affect the growth of colon 26-M3.1 cells. In contrast, IS-2 enhanced splenocyte proliferating activity in a dose-dependent manner. Peritoneal macrophages stimulated with IS-2 produced various cytokines, such as IL-1beta, IFN-gamma, and IL-12. In addition, treatment with IS-2 (20 microg/mouse) induced tumoricidal activity of peritoneal macrophages against colon 26-M3.1 cells. In an assay for natural killer (NK) cell activity, IS-2 (20 microg/mouse, i.v.) significantly augmented NK cytotoxicity against Yac-1 tumor cells at 2 days after IS-2 treatment. The depletion of NK cells by injection of rabbit anti-asialo GM1 serum abolished the inhibitory effect of IS-2 on lung metastasis of colon 26-M3.1 cells. These data suggest that IS-2 inhibits tumor metastasis via activation of macrophages and NK cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068098     DOI: 10.1016/j.intimp.2007.10.005

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  14 in total

1.  Effect of Beta glucan on quality of life in women with breast cancer undergoing chemotherapy: a randomized double-blind placebo-controlled clinical trial.

Authors:  Alireza Ostadrahimi; Ali Esfahani; Mohammad Asghari Jafarabadi; Jamal Eivazi Ziaei; Aliakbar Movassaghpourakbari; Nazila Farrin
Journal:  Adv Pharm Bull       Date:  2014-08-25

Review 2.  Lung cancer and β-glucans: review of potential therapeutic applications.

Authors:  Raheleh Roudi; Shahla Roudbar Mohammadi; Maryam Roudbary; Monireh Mohsenzadegan
Journal:  Invest New Drugs       Date:  2017-03-16       Impact factor: 3.850

3.  The involvement of NK cell activation following intranasal administration of CpG DNA lipoplex in the prevention of pulmonary metastasis and peritoneal dissemination in mice.

Authors:  Shuwen Zhou; Shigeru Kawakami; Yuriko Higuchi; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Clin Exp Metastasis       Date:  2011-11-04       Impact factor: 5.150

Review 4.  The Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy.

Authors:  Ahmed Gamal; Mohammed Elshaer; Mayyadah Alabdely; Ahmed Kadry; Thomas S McCormick; Mahmoud Ghannoum
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 5.  The mechanism of the anticancer function of M1 macrophages and their use in the clinic.

Authors:  Xing-Qing Pan
Journal:  Chin J Cancer       Date:  2012-11-13

Review 6.  Beta-glucan contamination of pharmaceutical products: How much should we accept?

Authors:  Claire Barton; Kim Vigor; Robert Scott; Paul Jones; Heike Lentfer; Heather J Bax; Debra H Josephs; Sophia N Karagiannis; James F Spicer
Journal:  Cancer Immunol Immunother       Date:  2016-07-29       Impact factor: 6.968

Review 7.  Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future.

Authors:  Khawaja Muhammad Imran Bashir; Jae-Suk Choi
Journal:  Int J Mol Sci       Date:  2017-09-05       Impact factor: 5.923

Review 8.  Immunostimulatory properties and antitumor activities of glucans (Review).

Authors:  Luca Vannucci; Jiri Krizan; Petr Sima; Dmitry Stakheev; Fabian Caja; Lenka Rajsiglova; Vratislav Horak; Mustafa Saieh
Journal:  Int J Oncol       Date:  2013-06-05       Impact factor: 5.650

9.  β-Glucan supplementation, allergy symptoms, and quality of life in self-described ragweed allergy sufferers.

Authors:  Shawn M Talbott; Julie A Talbott; Tracy L Talbott; Elaine Dingler
Journal:  Food Sci Nutr       Date:  2014-01-08       Impact factor: 2.863

10.  Immunosuppression of the trimellitic anhydride-induced th2 response by novel nonanatural products mixture in mice.

Authors:  Min-Jung Bae; Hee Soon Shin; Dong-Hwa Shon
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.